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Abstract
Dissemination of evidence-based programs and policies is a critical final step in reducing the
burden of cancer in the general public. Yet we have not been fully successful to date in improving
clinical or public health practice by disseminating programs found to be effective in research.
Therefore, research is needed into the dissemination process and outcomes, to enable better efforts
in the future. This paper explores the definitions and models used for dissemination, the designs of
dissemination studies, and possible research questions in dissemination research, all focused on
cancer prevention and control. We hope that this paper will encourage dissemination research in
our field.
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Introduction
Dissemination is an emerging and important issue in the field of cancer prevention and
control. Most agree that we currently do not adequately disseminate key findings and
programs to the practitioners that need them, yet dissemination is the logical and critical
final step in using a program, policy, or idea to improve cancer outcomes. One key reason is
that dissemination so rarely occurs is that we simply do not know how to effectively
disseminate programs once they are found to be effective, due to lack of research in this
area. Recent publications and conferences (e.g., have begun to move us toward development
of the science of dissemination, but we have a long way to go. Research is needed into how
we can most effectively disseminate evidence-based programs.
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The Cancer Prevention and Control Research Network is a national network of investigators
formed with one of its purposes to increasing research on the dissemination of programs and
interventions that have been found efficacious but have not been adopted as part of best
practices. The purpose of this paper is to provide researchers in cancer prevention and
control with a primer for engaging in active research on dissemination. First, we present a
working definition of dissemination research and related constructs, followed by a brief
review of models used in dissemination research and study designs used in this field,
together with methodological challenges. We discuss examples of possible research
questions, based on our analysis of models and methods. We hope that this paper will help
to clarify concepts and will also serve as a springboard to formulate future dissemination
research.
Definitions for this field
Finding a common ground of definition and conceptualization of what we mean when we
say dissemination research has been one of the key stumbling blocks in this field. Reports of
confusion in writing grants, designing measures, and studying the phenomenon of
dissemination have stemmed at least in part from the inconsistent definition of labels used to
define the study the dissemination of programs and policies. Increasing agreement on
definitions would help us to test competing models of dissemination as we move forward to
enhance this research field. Therefore, the first activity that we engaged in was to make a list
of definitions that have been used to describe the process of dissemination
Table 1 presents some definitions that have been articulated in the literature. The process of
moving tested public health programs and policies toward practice has been variously
termed dissemination, translation, implementation, and diffusion, with little agreement on
these terms. A recent RFA from the National Cancer Institute defines dissemination as
“targeted distribution of information and intervention materials to a specific public health or
clinical practice audience”. A related construct, implementation, is defined in this RFA as
“use of strategies to adopt and integrate evidence-based health interventions and change
practice patterns within specific settings”. The difference between these definitions seems to
be in the level of the product to be moved into practice (i.e., specific materials versus an
entire intervention). These definitions do not deal with any conceptually different issues and
do not indicate any particular process or engagement by the targeted practice setting in the
process. A recent RFA from the Centers for Disease Control and Prevention adds to the
issue by providing different and more detailed definitions of both dissemination and
implementation, and definitions of the related constructs of translation and diffusion, each
with overlapping content of previous definitions. Other investigators represented in Table 1
have offered specific definitions of all of these constructs, many of them overlapping with
the federal definitions, but none of them specific to cancer control and prevention. Other
differences include that the term dissemination sometimes focuses on clinical practice,
sometimes public health practice, or in some settings both. Dissemination can refer to the
target audience in an active, participatory manner, or not. Some citations promote
dissemination as the key overarching concept, and some see dissemination as a piece of the
process of implementing evidence-based practice. The CDC RFA definitions, for example,
focus more on the process of moving evidence to the public's use, while the NCI RFA
definitions focus on the outcome of the process (ie, having evidence based programs in
place). Clearly, this field needs to focus its definitions of key constructs to enable agreement
among scientists at all levels of involvement.
Examples of the importance of consistent definitions can be found in the cancer control
literature. For example, consider a program designed to increase mammography rates in a
target population by increasing the distribution and use of a tested flyer to inform patients of
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the benefits and reduce the perceptions of barriers of getting a mammogram. Research on
this issue would be conducted very differently considered using two different definitions of
dissemination to guide research, the Lomas 1991 (1) and the Curry 2000 definitions. The
Lomas 1991 definition calls for a relatively reactive process of targeted distribution, while
the Curry 2000 definition recognizes the reciprocity of the push of consumers for a specific
product or activity together with the pull of the system to increase interest and ultimately use
of the product by the target population. The overall outcomes of a research project might be
similar when the two definitions were considered, but the process of dissemination would be
very different, and therefore differentially successful, depending on the definition applied.
The process according to Lomas might be to monitor the uptake of materials sitting in a
waiting room in a clinical setting, while the Curry definition would be to distribute the same
materials to each patient's home, using active encouragement to use the tested materials.
These differences in definition make the design of a research project and comparison across
dissemination research studies complicated. For now, we need to identify a workable, simple
definition of dissemination research, useful for most applications in cancer control, and one
that can be refined and tested in future research projects and adapted to the specific setting
and target of dissemination. We recommend for now using the following definition of
dissemination research:
Understanding the process of moving evidence-based public health and clinical
innovations into practice settings.
This definition allows for research into the process of dissemination and for the
acknowledgement that improved practice is the ultimate goal of these activities. This
definition also allows for the more passive diffusion of a new idea into a system, or the more
active pushed and encouraged acceptance of a program into a system where there is less
pull. Other issues to be considered when defining dissemination research include the
following:
• What is the larger field as described in the definition above, and what shall we call
it? (not sure what this question gives us)
• What is the relationship between dissemination versus implementation? Are they
competing definitions or do they describe complementary elements of some larger
field?
• Does disseminating a scientific finding to practice settings use the same processes
as disseminating a program? Is dissemination of findings essentially policy, or is it
something else altogether?
• How much of dissemination is about the pull of practice needs and how much
occurs due to the push of disseminators? Are these different views of the same
process, or different processes? And does whether dissemination occur following
push or pull, determine the effectiveness of the effort?
There is no agreement regarding any of this among scientists, practitioners, or funders. Such
agreement could make dissemination research easier and less intimidating to grapple with,
as well as easier to test scientifically. We should all look for ways to harmonize in the next
phase of research by trying to formulate common definitions and questions and looking for
common concepts and methods. While we do that, it is important to be sensitive to target
audiences, including the funding audiences, as well as the practice audiences. Continued
work here at both the domestic and international levels is clearly needed.
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What is the necessary evidence base for moving to dissemination
research?
Dissemination research commences once there is sufficient evidence indicating that cancer
prevention and control interventions work with the ultimate aim of reducing cancer risk and
burden within the population. At what point do we recommend that the current best evidence
about a specific cancer prevention intervention is enough?(2) There is some debate in the
field regarding what constitutes sufficient evidence to move to dissemination, with
alternative paths leading us from the research evidence base to practice.(3,4) Understanding
this debate can help to inform dissemination research, the focus of this paper.
The predominant guiding paradigm for intervention research is a linear framework,
proceeding along a continuum in which each research phase sets the stage for a future step.
In their classic text, Greenwald and Cullen(5) applied this linear framework to cancer
prevention research, following several key steps: (1) basic research designed to identify the
nature of the problem and generate testable hypotheses; (2) methods development, including
development of assessment and intervention methods; (3) efficacy studies, designed to test
interventions under tightly controlled conditions(6-14); (4) effectiveness studies, taking the
next step of testing interventions under more “real-world conditions” (4,15); and (5)
demonstration and implementation, including dissemination research.(5) Others have
described the applicability of this linear framework to other disease outcomes, including for
example cardiovascular disease,(16) and mental health.(17).
In general, within the context of this linear framework it is understood that research may not
always proceed in a completely linear sequence, but rather may include some feedback
loops circling back to previous steps to address newly-defined research questions(5,6). This
might be true specifically for dissemination research, as if a program is not able to be moved
into public health or clinical practice, we could consider the development of other programs
that have a higher likelihood of spread.
Efficacy and Effectiveness Trials leading to Dissemination
Despite the considerable advantages of scientific rigor provided by the sequencing of
efficacy and effectiveness trials, some have raised concerns that efficacy and effectiveness
trials may not yield the “best candidate” interventions for dissemination.(1,10,15,18,19)
Interventions tested in efficacy trials, for example, are designed to maximize potential
effectiveness, and thus may be more intensive, costly, and complex than interventions that
can feasibly be disseminated on a broad scale. The required standardization of the
intervention in efficacy studies may actually limit the intervention's effectiveness by failing
to incorporate participant input and to adapt the intervention to the context and needs of the
setting.(20) The working linear framework connotes a uni-dimensional flow, with the tested
intervention being disseminated to the community, when in fact a bi-directional arrow may
better illustrate the need for researchers and intervention designers to better understand the
world of practice.(21,22) A further limitation to the generalizability of randomized trials is
the requirement that study participants agree to random assignment. Whether individuals or
groups (e.g., schools, clinics, worksites), participants in such studies may not be
representative of broader populations at diverse stages of readiness for change and
receptivity to the intervention. Thus, increasingly there are calls for research methods
emphasizing generalizability and feasibility of interventions, and the inclusion of contextual
information such as the representativeness of the population and the reach of the
intervention, as well on the needed adaptations.(4,23,24)
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One strategy for addressing these concerns is a movement away from the linear model and
its assumption that knowledge is a product of a linear progression through research phases,
to a systems framework.(24) Systems models of translation begin with an integration of
knowledge, with an understanding of the complexity of implementation and assuming that
dissemination is both contextual and embedded in relationships and in turn in organizations.
(25-27) The theories that underlie dissemination, described below, certainly need attention
of this type.
Knowledge synthesis – Making sense of the evidence base
One question for this field is how to make sense of individual studies that test single
intervention programs or policies. Single studies provide an important component of the
evidence base for dissemination, but are not generally considered sufficient evidence for
broad-scale dissemination. The peer review system provides a means of tracking individual
studies. Cancer PLANET and R-TIPS make the findings and interventions of these studies
readily accessible. There are a range of tools for synthesizing evidence across studies.
(1,28),(25,26,29,30) For example, meta-analysis provides a quantitative approach to
systematically cull and integrate the findings of multiple individual studies, with the goal of
finding consistent patterns or lack of agreement across the studies.
A leading public health synthesis method is the process leading to the Guide to Community
Preventive Services. The aim is to identify consistent findings from a series of well-designed
and rigorously implemented studies. Conclusions about the available evidence are based on
the number of studies, types of study designs used, the consistency of the findings, and the
effect sizes found, in combination with expert opinion.(31) The systematic nature of the
review for the Community Guide provides the basis for the “gold standard” of evidence,
based on rigorous scientific studies.(32) Other reviews take into account a broader definition
of evidence as they consider whether something “works”, such as the Intervention MICA,.
(33) and the E-Roadmap to Evidence-Based Public Health Practice.(34) These reviews
illustrate an increasing movement toward expanding the evidence base to include non-
randomized studies and the growing recognition of the roles that such trials can play in the
developing an integrated picture of the existing evidence.(30,35) Indeed, some have noted
that exclusion of these diverse study designs, including quasi-experimental designs, non-
randomized designs, and natural experiments, may bias the conclusions toward the types of
interventions and settings that are more readily tested through randomized trials, and thus
will lead to less effective dissemination efforts of these interventions.{Des Jarlais, 2004
#7860}
What actually gets disseminated?
Adapting previously tested interventions for a new population target before testing the
dissemination process is a matter of some controversy. Green(22) recommends that we
replace the expectation that health behavior research will produce “best practices” with
something more akin to “best practices for the process of planning for most appropriate
interventions for the population and setting.” Tested interventions need to be adapted and
often researched to assure that there is an appropriate fit between tested methods and the
context, setting, and the population's circumstances.(21) Both NCI and CDC have developed
a systematic process for adaptation of tested interventions.(36)a and b. This process begins
with the identification of both core and adaptive or “key” elements of the intervention, as
has also been noted by others.(37-42) Core elements are those intervention features that
must be replicated to maintain the integrity of the interventions as they are transferred to
new settings – as CDC defines them, those that are integral to the internal logic of the
intervention and required for its main effects. Key or adaptive characteristics are those
features of an intervention that can be tailored to organizational, social and economic
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realities of the new setting without diluting the intervention's effectiveness,(38) important
but not essential features of the intervention methods.(43) This process clearly requires
research that engages the community, systematically assesses the context, needs and
resources, and plans programs in response to those needs.(22) Understanding the process of
adapting the intervention is one needed component of dissemination research.
The dissemination research process also requires evidence on the translation of the research
into scalable and sustainable interventions. According to Kottke and Pronk,(44) scalability is
the ability to present the adaptation of the intervention to all members of the intended
audience, and sustainability is the ability to support, maintain, and enhance the application
over time. Thus the adaptation process may additionally include incorporation of strategies
to optimize the use of program components, for example through the addition of features
that situate the intervention within existing work flows and processes. Research into this
process includes a comparison of the environment and setting in which the intervention has
been tested, with those to which it will be adapted, in order to identify the types of
adaptations and measures needed.(37) The community will additionally be interested in
evidence of demand for an intervention, to assure that the intervention strategies are feasible,
acceptable and compatible with the lifestyle and social environment of the audience.(45)
In summary, there is a need for a balance in defining interventions that are ready for
dissemination research. As a field, we need to conduct dissemination research on
interventions that have been rigorously tested to assure that the observed changes in health
behaviors can truly be attributed to the intervention. We must also attend to the range of
study designs and study populations that allow for maximum external validity. We must
proceed on the basis of solid evidence, yet we are still defining that evidence base.
Available theoretical models for dissemination research
One of the key elements in designing a dissemination research project is to use theory in
designing the intervention, process measures, and outcome measures. A theory should: 1)
accurately describe a large class of observations on the basis of a model which contains only
a few arbitrary elements and 2) make definite predictions about the results of future
observations. (46) In comparison to models or frameworks, theories are explanatory as well
as descriptive, while models are only descriptive. (47) Rogers' Diffusion of Innovation
Theory (48) remains the fundamental model describing the processes of adoption of an
innovation and key factors that must be considered in attempting to disseminate an
innovation. While not empirically tested prospectively, this theoretical model has dominated
the published literature in this area and is characterized by a focus on the adoption process
and use of interventions/innovations as outcomes. The factors described as central to the
diffusion of interventions are characteristics of the innovation itself, properties of the
communication channel through which the intervention is disseminated, time from no use of
the intervention to full adoption across the population and the different activities that occur
across time, and characteristics of the social system in which the innovation is being
disseminated. These properties have been shown in various fields to be highly predictive of
successful adoption (48) For example, an intervention/innovation is more likely to be
adopted if it is perceived as (1) superior to the existing practice it replaces (relative or
perceived advantage), (2) consistent with the intended adopters' values, norms and perceived
needs and/or with organizational or professional norms, values and ways of working
(compatibility), (3) simple to use based on practical experience and/or demonstration
(complexity), (4) readily implemented in small steps and stages, (5) having observable
benefits for various audiences and within acceptable timeframes (observability), (6)
amenable to adaptation, refinement, or other modification to suit needs of potential adopters
(reinvention) and (7) open to experimentation within an organizational structure that bases
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change on results (trialability). (48,49) Even though the evidence supporting these attributes
is strong, these attributes are neither stable features of the intervention nor sure determinants
of their adoption. The interactions among the intervention, the intended adopter(s) and a
particular context determines adoption (49) along with individuals' perceptions of an
intervention and its attributes (48). In addition to these key elements of diffusion, Rogers
describes five stages of the innovation at an organizational level: agenda setting, matching
the problem to the relevant innovation, re-defining and restructuring both the innovation and
the organizational structure, clarifying the relationship between the organization and the
innovation or intervention and routinizing, or making the innovation an ongoing part of the
organization's activities.
Other models might be used in the definition and study of the dissemination process, but
have to date received no empirical reports: a map of the program adaptation (43), the
systems model of translational research (50), Community Organizing models (51) and
Social Marketing Theory (52). Future research could research and refine these potentially
useful theories, applied to dissemination research In addition, some frameworks, such as
Glasgow's RE-AIM framework (53), Kerner's discovery to delivery continuum (54) and
Orleans push pull synergistic framework (55), are not technically dissemination theories but
have certainly been used to describe the dissemination process and to outline process
evaluation in this field. In particular, RE-AIM provides a useful framework for evaluating
the dissemination process. The RE-AIM evaluative framework includes five elements of
dissemination research projects: reach, effectiveness, adoption, implementation, and
maintenance. Reach is defined as the percent of potentially eligible individuals in the target
population who receive the intervention and how representative they are of the population
from which they come. Effectiveness refers to the intended results of the intervention and its
possible consequences on the primary outcomes of interest. Adoption measures the uptake
of the intervention(s) within targeted settings and among targeted providers within settings
while Implementation describes the quantity and quality of delivery of the intervention
components. Maintenance describes the long-term results of the program (e.g. at the
individual or population level of outcomes) and/or the institutionalization of the program in
the setting as a part of usual practice awareness, adoption, implementation, and maintenance
in health settings. The application of RE-AIM as an evaluative framework helps assess
external validity (reach and adoption) as well as internal validity (efficacy and
implementation). (56).
Where does this leave us in the area of theoretical models for dissemination research? None
of these models were developed specifically for dissemination research, a gap that is
important, as none of the models completely describe the continuing challenges and issues
when one conducts a study in this area. We feel that when designing a dissemination
research project in cancer control, one must critically assess the appropriateness of any new
model for the proposed research. Further, one must integrate the components of various
models as appropriate for a particular type of dissemination research, with a focus on new
model development and testing. Consideration of systems thinking is critical to this theory
development, as much of dissemination goes on at the systems level, and more traditional
individualistic perspectives will not be fully useful. This is an area of scientific inquiry that
should be pursued by all researchers in this area.
Methodological considerations in this field
As noted earlier, dissemination and implementation research can be conducted using
experimental, quasi-experimental, or non-experimental research designs. Several recently
published articles describe the strengths, limitations, and tradeoffs of the many study designs
that investigators could use in dissemination and implementation research (57) We do not
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intend to review those discussions here. Instead, we wish to raise four points that previous
discussions either have mentioned only in passing or have not identified as potential
concerns.
Selection of study design
First is the issue of selecting study designs. Much of the recent discussion of research design
has focused on the relative merits of various study design options for evaluating
dissemination and implementation strategies. For example, Mercer and her colleagues (57)
provide a thorough review of the relative merits of several experimental and quasi-
experimental designs for conducting dissemination research. However, as they and others
acknowledge, study designs for assessing causality, such as a randomized trial with pre and
post measures, are often not the best designs for investigating non-causal questions. Other
methods, like qualitative research methods, computer simulation, survey research methods,
and cost-effectiveness methods, can be useful for answering important descriptive and
process-related questions, such as:
• Who is the appropriate target or audience for dissemination?
• What implementation needs exists, and how do those needs vary across contexts?
• How receptive are practitioners to various dissemination and implementation
strategies?
• How should dissemination and implementation strategies be designed?
• What does dissemination and implementation look like in practice?
• How feasible are dissemination and implementation strategies in particular
contexts?
• How much does a strategy cost, and how do those costs vary across contexts?
• What would it take to sustain an effective strategy?
Given the current state of knowledge, investigation of such non-causal questions would
make a significant contribution. While experimental designs remain the gold standard for
assessing causality, the choice of research design for dissemination research should be
driven by the research question itself.
Matching study design to setting
Second, the knowledge that can be gained from efficacy or effectiveness studies of specific
dissemination and implementation strategies depends heavily on the careful matching of the
strategy and the study setting. For example, several systematic reviews find that strategies
for disseminating and implementing clinical guidelines exhibit modest and often mixed
effects in terms of guideline use and improvements in care. The general conclusion one can
draw from this substantial body of research is that no single strategy or combination of
strategies works all of the time; rather, strategies work best when they match the
determinants of the problem. To illustrate, strategies involving reminders are likely to
effective if the principal reason why clinicians in a given setting are not using guidelines is
that they lack the necessary cues-to-action. However, if the principal reason why clinicians
in a given setting are not using guidelines is that they do not believe the guidelines are
appropriate or, alternatively, they believe in the guidelines but they cannot act on them
because of work load or work flow, then strategies involving reminders are likely to produce
little or no effect. In conducting dissemination research, therefore, investigators must
carefully select intervention sites to ensure that a good match exists between the
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dissemination strategy or strategies and the principal determinants of the problem in that
local setting.
Choice of dependent variable
Third, the choice of dependent variables in dissemination and implementation research
depends on how one conceptually defines dissemination and implementation. As stated in
Table 1, the NIH RFA for dissemination and implementation research defines dissemination
as the targeted distribution of information and intervention materials to a specific public
health or clinical practice audience. The aim of dissemination, according to this view, is to
spread knowledge and the associated evidence-based interventions to practice settings.
Given this definition, the proximal outcomes for gauging the effectiveness of a
dissemination effort might include increased awareness and understanding of the
intervention being disseminated, increased willingness to engage with that intervention, and
increased behavioral capability to apply the chosen intervention activities in the specific
setting. Behavior change resulting from use of that intervention is a more distal outcome of
that dissemination research project. Whether dissemination efforts produce behavior change
depends on additional, situational factors such as resource availability, time availability,
competing priorities, and coordination with others. Likewise, the NIH defines
implementation as the use of strategies to introduce or change evidence-based health
interventions within specific settings. According to this view, the aim of implementation is
to put into practice new ideas, technologies, policies, or practices. Given this definition, the
proximal outcomes for gauging the effectiveness of an implementation effort might include
the consistency, quality, and appropriateness of initial or early use of the new idea,
technology, policy, or practice. The benefits that result from initial or early use (e.g.,
reduced morbidity or mortality) are less proximal outcomes of implementation. Whether
implementation produces anticipated benefits depends on additional factors, such as whether
the efficacy of the new idea, technology, policy or practice remains intact following
implementation.
As we noted earlier, the NIH definitions of dissemination and implementation are not the
only ones available. Investigators employing alternative definitions might hold differing
views about appropriate primary and secondary dependent variables in dissemination and
implementation research. Regardless of the definition used, however, careful consideration
must be given to selection of the dependent variable.
Measurement issues
Finally, previous discussions of research designs appropriate for dissemination and
implementation research (57-63) have focused almost entirely on the relative importance of
internal and external validity and the trade-offs inherent in specific study designs with
respect to these two concerns. The issue of construct validity of measures, by contrast, has
garnered much less attention, despite the fact that poor measurement construct validity can
undermine a study's contribution to both theory and practice. Construct validity refers to the
degree to which inferences can legitimately be made from operational definitions to
theoretical constructs (64). Construct validity can be viewed as a “labeling” issue. Do the
concrete operations in a give study (e.g., the actual programs, interventions, or measures that
get used) fully and faithfully reflect the concept, idea, or theory that they purportedly
represent or manifest? Some threats to construct validity, such as poor conceptualization of
constructs or over-generalizing from limited levels (i.e., doses or intensities) of constructs,
can be addressed by careful labeling and description of dissemination and implementation
strategies and their components. Other construct validity threats can be partially controlled
through research design choices. For example, experimenter expectancies can be controlled
by assigning to different research personnel the data collection and data analysis tasks.
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Likewise, compensatory rivalry (i.e., control sites trying harder) and resentful
demoralization (i.e., control sites giving up) can be controlled by offered the control group
sites delayed intervention or alternative intervention. Finally, contamination can be
controlled by spatially or temporally separating control and intervention sites. Other
construct validity threats, however, are difficult to address in dissemination and
implementation research. For example, construct confounding can occur when intervention
sites or study participants engage in co-intervention—that is, when they engage additional
activities that support dissemination and implementation that the investigator does not know
about or intend. The stronger the intervention sites' or study participants' commitment to the
success of the dissemination or implementation effort, the stronger the temptation they face
to “stack the deck” in favor of a positive outcome, even if it means deviating from the study
protocol. Similarly, dissemination and implementation may be particularly susceptible to
novelty and disruption effects, as dissemination and implementation efforts often introduce
something new to intervention sites or study participants. Bracht and Glass (1968) suggested
that introducing an innovation can breed excitement, energy and enthusiasm that contribute
to success, especially if little previous innovation has occurred. Alternatively, introducing an
innovation can provoke resistance, especially if it disrupts existing routines. In either case,
novelty or disruption represents a construct confounder that renders the results of a study
more difficult to interpret, even when the plausibility of causal inference seems strong.
Simply anticipating and assessing these types of effects is the best strategy, as then they
become part of the scientific record of what has happened in a dissemination research
project.
Possible Research Questions to Move the Field of Dissemination Research
Forward
In general, systematic research on dissemination of public health promotion programs is in
its infancy. As noted above, theories and models need to guide such research; however,
relatively few comprehensive models exist. Research questions abound, in terms of
understanding the process and outcomes of dissemination. If we think about dissemination
research as understanding the way that new innovations spread into society (both public
health and clinical practice) then numerous unanswered questions can be posed. One way of
defining relevant research questions is to examine gaps in research using four categories
taken from Rogers' theoretical model, including (1) characteristics of: the innovation, (2)
properties of the communication channel, (3) activities over time, and (4) the environment/
system in which the dissemination is to occur. We have selected 3 dissemination research
foci to use as examples, presented in Table 2.
First, understanding the characteristics of the innovation is a key first step toward promoting
its dissemination. Marketers have tremendous expertise in identifying unmet needs in their
audiences and finding effective ways to create awareness and adoption by branding and
promoting new products, but we know less about how to accomplish this in the public health
arena. It cannot be overemphasized that careful formative research is critical in order to
determine the needs/preferences of each target audience. For example, studies could
examine views about the acceptability of new technological advances in different
populations. Consuming fruits and vegetables is a common occurance in most people's diet,
although not at the level needed to promote health. Awareness of HPV risk and potential
vaccination for risk reduction, however, is likely to be low in situations where awareness of
other sexually transmitted diseases is low and/or not an accepted topic of discussion.
Little research has rigorously examined specific intervention characteristics (e.g. trialability,
flexibility, relative advantage, etc) to determine which ones are most operational in different
types of organizations and/or with different types of interventions. For example, flexibility
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may be very important in disseminating programs aimed at organizations with a high degree
of autonomy or with a lot of decentralized authority, such as churches. However, flexibility
might be less important or even counter-productive in highly centralized organizations
where fidelity to protocols or regulations is very important, for example in the dissemination
of an evidence-based clinical practice in a hospital system.
Selecting the appropriate communication channel to transmit the package for dissemination
is an important issue. For example, influencing provider recommendation behaviors has
been shown to be difficult REF, partly due to the lack of an acceptable channel for
disseminating new ideas. Delivering knowledge and support for using evidence-based
screening promotion programs to providers, for example, could occur through continuing
medical education sessions, through use of a web-based portal for provider education and
support, or through advice from a trusted colleague, as in academic detailing. Or, as in many
programs, a combination of these channels could be tested. The same channels would likely
not work to disseminate and promote the use of a new vaccine for HPV risk reduction. For
this research question the providers themselves could become the channel of dissemination,
with appropriate support to patients.
Time is the third key factor in Rogers' model, containing many elements. Some research
questions relevant to time might focus on studying how quickly systems and environments
promote use of a new program or benefit, (e.g. relative impact of top-down directives,
participatory strategies, interpersonal communication via viral marketing or lay health
advisors), or the relative impact of these factors in a given subpopulations populations of
workplaces or health care settings. Early adopters, those who use innovations early in the
dissemination process, are likely to be different from those who are later adopters of the
innovation. Therefore, motivations tailored to the adopter characteristics at different stages
over time might be tested. For example, early parental adopters of the HPV vaccine might
have strong beliefs that the health care system is trustworthy, while late adopters might
express mistrust in the health care system as solution for preventing disease. In addition,
how much support over time (e.g. technical, peer, supervisory, etc.) is needed to achieve
adequate implementation once interventions move from researcher control to community
control over program implementation and fidelity is a key issue. What system factors
promote or hinder implementation (e.g. program novelty, personal commitment to the
program/outcomes, personnel resistance/overwork, competing priorities, lack of belief in
benefits) and how does this vary across systems? For example, difficulties in using evidence
based programs in clinical settings might be due to lack of experience with electronic
medical records, which might be an innovation themselves and might come to publically
funded community clinics late in the process. Additional research questions might focus on
later stages, such as factors necessary to establish program maintenance and indeed, what
defines maintenance.
In addition, much research is needed to understand the characteristics of groups that exert
their influence at different points in the dissemination process. We know, for example, that
the role of program champions and opinion leaders can be critical in disseminating
evidence-based programs and information in both clinical and community contexts.
However, less is known regarding the specific contexts and settings in which opinion leaders
may be most effective. In addition, who are these champions/pioneers and how do we best
identify and train them? In a recent study, Grimshaw and colleagues surveyed professional
groups in the UK National Health Service to determine factors impacting effectiveness of
opinion leaders, such as extent of social networks and types of identification processes (65).
In another example, Valente and Pumpuang (66) recently reviewed over 200 studies
utilizing different techniques and methods of identifying opinion leaders, in order to study
factors such as relative effectiveness and convergence of these methods in identifying
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individuals to serve in this capacity. In addition to identification of these groups, we need to
know the impact of utilizing such champions/leaders in terms of their personal and
professional growth, reputation and status, role conflict and burden, or other positive or
negative consequences.
Finally, characteristics of the social system that is the intended target of the dissemination
process need research attention. For example, disseminating a mass media program kon fruit
and vegetable consumption to a large geographic area may not be the most efficient method
of reaching the target audience to to lack of exposure to the media outlet, such as a billboard
on the highway. Differences among clinics' resources and support will, in part, determine the
amount of evidence based programs that can be incorporated into standard practice.
It is important to differentiate between research questions that truly focus on dissemination
research, versus other types of research questions that are important and relevant, but don't
speak specifically to dissemination. For example, a study that seeks to determine whether an
intervention with proven efficacy in one population can be translated to another population
or setting may be better characterized as a replication study, and not a dissemination study.
As the field matures and agrees upon needed research strategies, we will likely be able to
make these distinctions more easily.
Conclusions
One thing is clear: We need more high quality research into the dissemination of cancer
prevention and control programs. For every question that we have answered, several more
are identified and need addressing. This is an exciting time in the field, as we have the
potential to see much of the past 30 years' worth of work put into practice over the next 30,
if we guide it wisely with research into the guidance process.
One improvement that we recommend in the field is to consider a focus on common phases
or stages, on key common process and outcome variables, and on common theoretical
models that drive all of these choices. This will give us the ability to accept or reject these
strategies if we identify multiple tests on the same measures, channels, and phases. Research
questions are varied and should include process and component variables appropriate to the
setting. Acceptance of alternative designs is another issue that we need to improve in the
field, in that the randomized trial is not always feasible and not always practical.
Our previous 30 years has taught us that dissemination does not just happen if we wait for it.
New information is often needed to make it happen. Let's consider this a call to action, to
gather that new information in support of making it happen.
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Table 1
Definitions available in the literature for dissemination research.
Source Dissemination Translation Implementation Diffusion
NCI RFA The targeted distribution of
information and intervention
materials to a specific public
health or clinical practice
audience. The intent is to spread
knowledge and the associated
evidence-based interventions.





CDC RFA The systematic study of how the
targeted distribution of
information and intervention
materials to a specific public
health audience can be
successfully executed so that
increased spread of knowledge
about the evidence-based public
health interventions achieves















The systematic study of how a
specific set of activities and




settings (e.g., primary care
clinic, community center,
school).
The systematic study of
the factors necessary for
successful adoption by
stakeholders and the
targeted population of an
evidence-based
intervention which results
in widespread use and
specifically includes the
uptake of new practices











The process of putting a
defined practice or program
into practical effect; to pursue
to a conclusion
Lomas 1993 the targeted distribution of
information and intervention
materials to a specific public
health or clinical practice audience





Curry, 2000 Effective dissemination is a push-
pull process. Those who adopt
innovations must want them or be
receptive (pull) while there is
systematic effort to help adopters
implement innovation (push).
Tacit knowledge from experience
drives pull, explicit knowledge
from research drives push.
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Table 2
Applying diffusion theory to cancer prevention and control
Elements of Diffusion Theory
Research question The innovation Communication channel Time Social system












Electronic medical record, linked
to provider office and patient















How can we increase use
of previously tested mass
media spots that encourage
consumption of 5 servings











that engage commercial entities
in considering ethical business
practices, including free health
promotion media spots















the spots will be found.
How can we increase the














school girls and their
parents or guardians.
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